Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on November 19, 2020, Foghorn Therapeutics Inc. (the "Company") entered into a Loan and Security Agreement (the "Loan Agreement") with Oxford Finance LLC, a Delaware limited liability company ("Oxford"), in its capacity as a Lender (as defined in the Loan Agreement) and as collateral agent, as subsequently amended by the First Amendment to Loan and Security Agreement dated as of June 14, 2021, among Oxford and the Company. On August 30, 2021, the Company and Oxford entered into a Second Amendment to Loan and Security Agreement (the "Amendment"). Pursuant to the Amendment, the definition of "Second Draw Period" has been amended to mean the period commencing on the Second Draw Period Commencement Date (as defined in the Loan Agreement) and ending on the earlier of (i) October 15, 2021, and (ii) the occurrence of an Event of Default (as defined in the Loan Agreement). The foregoing is only a summary of the material terms of the Amendment and does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment (a copy of which is filed as Exhibit 10.1 attached hereto).




Item 9.01  Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.                                          Description

  10.1               Second Amendment to Loan and Security Agreement dated as of August
                       3    0    , 2021, among Oxford Finance LLC and Foghorn Therapeutics Inc.

© Edgar Online, source Glimpses